|
1
|
DeCamp MM Jr, Metzer SJ, Swanson SJ and
Sugarbaker DJ: Malignant effusive disease of the pleura and
pericardium. Chest. 112(4 Suppl): S291–S295. 1997. View Article : Google Scholar
|
|
2
|
Naylor B: Pleural, peritoneal, and
pericardial fluids. Comprehensive cytopathology. Bibbo M: 2nd
edition. WB Saunders; Philadelphia: pp. 551–621. 1997
|
|
3
|
Johnston WW: The malignant pleural
effusion. A review of cytopathologic diagnosis of 584 specimens
from 472 consecutive patients. Cancer. 56:905–909. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sahn SA: Malignant pleural effusions.
Fishman's Pulmonary Diseases and Disorders. Fishman AP, Elias JA,
Fishman JA, Grippe MA, Kaiser LR and Senior RM: 3rd edition.
McGraw-Hill; New York, NY: pp. 1429–1438. 1998
|
|
5
|
Das DK: Serous effusions in malignant
lymphoma: a review. Diagn Cytopathol. 34:335–347. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weick JK, Kieley JM, Harrison EG Jr, Carr
DT and Scanlon PW: Pleural effusion in lymphoma. Cancer.
31:848–853. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Berkman N, Breuer R, Kramer MR and
Polliack A: Pulmonary involvement in lymphoma. Leuk Lymphoma.
20:229–237. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Das DK, Gupta SK, Ayyagari S, Bambery PK,
Datta BN and Datta U: Pleural effusions in non-Hodgkin's lymphoma.
A cytomorphologic, cytochemical and immunologic study. Acta Cytol.
31:119–124. 1987.
|
|
9
|
Alexandrakis MG, Passam FH, Kyriakou DS
and Bouros D: Pleural effusions in hematologic malignancies. Chest.
125:1546–1555. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Uchiyama K, Kobayashi Y, Tanaka R, et al:
Primary malignant lymphoma of the central nervous system presenting
with ascites and pleural effusion. Hematologica (Budap).
30:143–148. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Watanabe N, Sugimoto N, Matsushita A, et
al: Association of intestinal lymphoma and ulcerative colitis.
Intern Med. 42:1183–1187. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Das DK, Gupta SK, Datta U, Sharma SC and
Datta BN: Malignant lymphoma of convoluted lymphocytes: diagnosis
by fine needle aspiration cytology and cytochemistry. Diagn
Cytopathol. 2:307–311. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fraser RS, Muller NL, Colman N and Pare
PD: Pleural Effusion. Fraser and Pare's Diagnosis of Diseases of
the Chest. 4th edition. WB Saunders; Philadelphia: pp. 2759–2760.
1999
|
|
14
|
Johnson EJ, Scott CS, Parapia LA and Stark
AN: Diagnostic differentiation between reactive and malignant
lymphoid cells in serous effusions. Eur J Cancer Clin Oncol.
23:245–250. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dunphy CH: Combined cytomorphologic and
immunophenocytic approach to evaluation of effusion for
lymphomatous involvement. Diagn Cytopathol. 15:427–430. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Paner GP, Jensen J, Foreman KE and Reyes
CV: HIV and HHV-8 negative primary effusion lymphoma in a patient
with hepatitis C virus-related liver cirrhosis. Leuk Lymphoma.
44:1811–1814. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang Q, Chang KL, Gaal K and Arber DA:
Primary effusion lymphoma with subsequent development of a small
bowel mass in an HIV-seropositive patient: a case report and
literature review. Am J Surg Pathol. 26:1363–1367. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Michai M, Goto H, Hattori S, et al:
Soluble CD30: a possible serum tumor marker for primary effusion
lymphoma. Asian Pac J Cancer Prev. 13:4939–4941. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ariad S, Benharroch D, Lupu L, Davidovici
B, Dupin N and Boshoff C: Early peripheral lymph node involvement
of human herpesvirus 8-associated body cavity-based lymphoma in a
human immunodieficiency virus-negative patient. Arch Pathol Lab
Med. 124:753–755. 2000.PubMed/NCBI
|
|
20
|
Mate JL, Navarro JT, Ariza A, et al: Oral
solid form of primary effusion lymphoma mimicking plasmablastic
lymphoma. Hum Pathol. 35:632–635. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aoki Y and Tosato G: Vascular endothelial
growth factor/vascular permeability factor in the pathogenesis of
primary effusion lymphomas. Leuk Lymphoma. 41:229–237. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kirn D, Mauch P, Shaffer K, et al:
Large-cell and immunoblastic lymphoma of the mediastinum:
prognostic features and treatment outcome in 57 patients. J Clin
Oncol. 11:1336–1343. 1993.PubMed/NCBI
|
|
23
|
Morel P, Dupriez B, Plantier-Colcher I, et
al: Long-term outcome of follicular low-grade lymphoma. A report of
91 patients. Ann Hematol. 66:303–308. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sandlund JT, Crist WM, Abromowitch M, et
al: Pleural effusion is associated with poor treatment outcome in
stage III small non-cleaved cell lymphoma. Leukemia. 5:71–74.
1991.PubMed/NCBI
|
|
25
|
Kabat-Koperska J, Kutrzeba J and Chosia M:
Acute kidney failure and ascites in Burkitt's lymphoma of the
stomach. Pol Arch Med Wewn. 105:67–70. 2001.(In Polish).
|
|
26
|
Klumb CE, de Resende LM, Stefanoff CG,
Vicuña CH, Renault IZ and Maia RC: Burkitt-like lymphoma in an
infant: a case report. Rev Hosp Clin Fac Med Sao Paulo. 58:33–36.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lerza R, Botta M, Barsotti B, et al:
Dexamethazone-induced acute tumor lysis syndrome in a T-cell
malignant lymphoma. Leuk Lymphoma. 43:1129–1132. 2002. View Article : Google Scholar : PubMed/NCBI
|
